Chartsonlygoup's future update (it'll live): tomwong.xyz/stock-status/

  Walgreens Boots Alliance Inc ( WBA ) |
2015 - 2021 (7 years)

Net Revenue (Sales) is 
$136.5B (1Y -1.72% )

WBA Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for WBA competitors.
PETS BIOS CVS RAD VSI
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2021 $69.1B -0.2x
( -2.7% / year avg)
chevron_left 2015 $83.9B
vertical_align_top Peak $165.3B +1.39x
vertical_align_bottom Bottom $69.1B
arrow_drop_up # Up Years 5 5 of 7
years up.
arrow_drop_down # Down Years 2
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • WBA's stock price has rallied +33,562% from $0.1 in 2015 , or -1673.1x faster than it's net revenue (sales) over the same period.
  • If WBA shrinks it's stock at the same rate as it's net revenue (sales) (-2.7%/year) , it's stock price will shrink +76.1% and hit $26.7 over the next 10 years.
  • WBA's stock price has gone up 1 of the 5 years (+20%) it's net revenue (sales) were also up.
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    1 Revenue 139537000000 136866000000 131537000000 118214000000 117351000000
    2 Cost of Revenue 111520000000 106790000000 100745000000 89052000000 87477000000
    3 Gross Profit (Income) 28017000000 30076000000 30792000000 29162000000 29874000000
    4 R&D 0.00 0.00 0.00 0.00 0.00
    5 SG&A 27045000000 25242000000 24569000000 23740000000 23910000000
    6 Other Expenses 70000000 233000000 177000000 -11000000 -261000000
    7 Operating Expenses 27045000000 25242000000 24569000000 23740000000 23910000000
    8 Interest Expense 639000000 704000000 616000000 693000000 596000000
    9 D&A 1927000000 2038000000 1770000000 1654000000 1718000000
    10 EBITDA 2899000000 6872000000 7993000000 7076000000 7682000000
    11 Operating Income 972000000 4834000000 6223000000 5422000000 5964000000
    12 Other Income Expenses (Net) 411000000 397000000 368000000 124000000 -224000000
    13 Pre-Income Tax 743000000 4527000000 5975000000 4853000000 5144000000
    14 Income Tax Expense 360000000 588000000 998000000 760000000 997000000
    15 Net Income 456000000 3982000000 5024000000 4078000000 4173000000
    16 EPS 0.53 4.32 5.07 3.80 3.85
    17 EPS Diluted 0.53 4.31 5.05 3.78 3.82
    18 Shares Outstanding 866500000 921500000 991000000 1073500000 1083100000
    19 Shares Outstanding (Diluted) 867100000 923500000 995000000 1078500000 1091100000
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    1 Cash & Cash Equivalents 516000000 1023000000 785000000 3301000000 9807000000
    2 Short Term Investments 0.00 0.00 0.00 0.00 0.00
    3 Cash & S-T Investments 516000000 1023000000 785000000 3301000000 9807000000
    4 Accounts Receivables 7132000000 7226000000 6573000000 6528000000 6260000000
    5 Inventory 9451000000 9333000000 9565000000 8899000000 8956000000
    6 Other Current Assets 974000000 1118000000 923000000 1025000000 860000000
    7 Total Current Assets 18073000000 18700000000 17846000000 19753000000 25883000000
    8 PP&E 35065000000 13479000000 13911000000 13642000000 14335000000
    9 Goodwill 15268000000 16560000000 16914000000 15632000000 15527000000
    10 Intangible Assets 10753000000 10876000000 11783000000 10156000000 10302000000
    11 Goodwill & Intangible Assets 26021000000 27436000000 28697000000 25788000000 25829000000
    12 L-T Investments 7338000000 6851000000 6610000000 6320000000 6174000000
    13 Tax Assets 0.00 0.00 0.00 0.00 0.00
    14 Other Non-Current Assets 677000000 1133000000 1060000000 506000000 467000000
    15 Total Non-Current Assets 69101000000 48898000000 50278000000 46256000000 46805000000
    16 Other Assets 0.00 0.00 0.00 0.00 0.00
    17 Total Assets 87174000000 67598000000 68124000000 66009000000 72688000000
    18 Accounts Payables 14458000000 14341000000 13566000000 12494000000 11000000000
    19 S-T Debt 3539000000 5738000000 1966000000 251000000 323000000
    20 Income Tax Payables 0.00 0.00 0.00 0.00 0.00
    21 Deferred Revenue 1498000000.00 0.00 0.00 0.00 0.00
    22 Other Current Liabilities -2000000.00 0.00 0.00 4245000000.00 4086000000.00
    23 Total Current Liabilities 27070000000 25769000000 21667000000 18547000000 17013000000
    24 L-T Debt 12203000000 11098000000 12431000000 12684000000 18705000000
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
    1 Net Income (Earnings) 456000000 3982000000 5024000000 4078000000 4173000000
    2 D&A 1927000000 2038000000 1770000000 1654000000 1718000000
    3 Deferred Income Tax -43000000 100000000 -322000000 -434000000 -442000000
    4 Stock-Based Compensation (SBC) 137000000 119000000 130000000 91000000 115000000
    5 Change in Working Capital -1928000000 -3248000000 -5027000000 -7664000000 5770000000
    6 Accounts Receivables 163000000 -789000000 -391000000 -153000000 115000000
    7 Inventory 63000000 141000000 331000000 98000000 -644000000
    8 Accounts Payables -25000000 954000000 1323000000 1690000000 1572000000
    9 Other Working Capital -8997000000 -7069000000 -3821000000 1206000000 8870000000
    10 Other Non-Cash Items 464000000 302000000 296000000 364000000 148000000
    11 Net Cash Provided by Operating Activities 5484000000 5594000000 8265000000 7251000000 7847000000
    12 Investments in PP&E -1374000000 -1702000000 -1367000000 -1351000000 -1325000000
    13 Acquisitions (Net) -718000000 -741000000 -4793000000 -88000000 103000000
    14 Purchase of Investments 0 0 0 0 0
    15 Sales/Maturities of Investments 0 0 0 0 0
    16 Other Investing Activities 71000000 133000000 659000000 152000000 160000000
    17 Net Cash used for Investing Activities -1297000000 -2307000000 -5501000000 -843000000 -3517000000
    18 Debt Repayment -21414000000 -10461000000 -4890000000 -6196000000 -791000000
    19 Common Stock Issued 0 0 0 0 0
    20 Common Stock Repurchased -1589000000 -4160000000 -5228000000 -5220000000 -1152000000
    21 Dividends Paid -1747000000 -1643000000 -1739000000 -1723000000 -1563000000
    22 Other Financing Activities -158000000 74000000 -98000000 -45000000 -143000000
    23 Net Cash Used Provided by Financing Activities -4647000000 -3047000000 -5295000000 -12934000000 2606000000
    24 Net Change in Cash -460000000 232000000 -2516000000 -6506000000 6807000000
  • About
    Industry: Pharmaceutical Retailers
    Sector: Healthcare
    Country: US
    IPO Date: 12/31/2014
    Stonk Exchange: NASDAQ
    • Walgreens Boots Alliance, Inc
    • engages in the provision of drug store services.
    • The company is headquartered in Deerfield, Illinois and currently employs 232,000 full-time employees.
    • The firm is a pharmacy-led health and wellbeing company.
    • The firm operates through three segments: Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale.
    • The Retail Pharmacy USA segment consists of the Walgreen Co.
    • (Walgreens) business, which includes the operation of retail drugstores, care clinics and providing specialty pharmacy services.
    • The Retail Pharmacy International segment consists primarily of the Alliance Boots pharmacy-led health and beauty stores, optical practices and related contract manufacturing operations.
    • The Pharmaceutical Wholesale segment consists of the Alliance Boots pharmaceutical wholesaling and distribution businesses.
    • The firm's portfolio of retail and business brands includes Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as global health and beauty product brands, including No7, Botanics, Liz Earle and Soap & Glory.